Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
1,25-Dihydroxyvitamin D3 is a negative endocrine regulator of the renin-angiotensin system
Yan Chun Li, … , Shu Q. Liu, Li-Ping Cao
Yan Chun Li, … , Shu Q. Liu, Li-Ping Cao
Published July 15, 2002
Citation Information: J Clin Invest. 2002;110(2):229-238. https://doi.org/10.1172/JCI15219.
View: Text | PDF
Article

1,25-Dihydroxyvitamin D3 is a negative endocrine regulator of the renin-angiotensin system

  • Text
  • PDF
Abstract

Research Article

Authors

Yan Chun Li, Juan Kong, Minjie Wei, Zhou-Feng Chen, Shu Q. Liu, Li-Ping Cao

×

Figure 6

Options: View larger image (or click on image) Download as PowerPoint
Renin upregulation is independent of the calcium status. (a and b) Blood...
Renin upregulation is independent of the calcium status. (a and b) Blood ionized calcium levels (a) and serum iPTH concentrations (b) in wild-type (white bars) and VDR–/– (black bars) mice at 20 days of age, at 3 months of age, or treated with the HCa-Lac diet for 5 weeks (5 wks Ca). *P < 0.01 vs. corresponding wild-type value; n ≥ 5 in each group. Note that the white bars are barely visible in b. (c) Northern blot analysis of renal renin mRNA from 20-day-old wild-type and VDR–/– mice. (d) Quantitative data of the Northern blot analyses from 20-day-old mice. *P < 0.001 vs. wild-type mice. (e) Northern blot analysis of renin mRNA expression in the kidney of wild-type and VDR–/– mice treated with the HCa-Lac diet for 5 weeks. (f) Quantitative result of the Northern blot analysis in shown in e. *P < 0.001 vs. wild-type mice. (g) Plasma Ang II concentrations of the mice analyzed in e. *P < 0.01 vs. wild-type mice; n = 5 in each genotype.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts